PRODUCT LITERATURE

FOLFOX and FOLFIRI use in Stage IV Colon Cancer: Analysis of SEER-Medicare Data

---

Shortly after the year 2000, randomized trials demonstrated that patients with metastatic colon cancer treated with infusional 5-fluorouracil (5FU)/leucovorin with either oxaliplatin (FOLFOX) or irinotecan (FOLFIRI) had a comparable progression-free survival benefit versus patients who received 5FU/leucovorin alone. Factors associated with the initial receipt of the FOLFOX or FOLFIRI regimen are unknown. Our goal was to investigate the patterns and predictors of use for first-line FOLFOX and FOLFIRI

---

Availability

Detail Information

Series Title

-

Call Number

-

Publisher

: .,

Collation

-

Language

English

ISBN/ISSN

-

Classification

NONE

Content Type

LITERATURE

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

Oxaliplatin

Specific Detail Info

Clin Colorectal Cancer. 2019 June ; 18(2): 133–140

Statement of Responsibility

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment